Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-11-16 Purchase | 2023-11-16 4:37 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 20,000 | $2.46 | $49,200 | 527,114 (Direct) | View |
2023-06-23 Purchase | 2023-06-26 4:14 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 38,364 | $3.91 | $150,003 | 507,114 (Direct) | View |
2023-04-10 Purchase | 2023-04-11 5:40 pm | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 468,750 | $1.6 | $750,000 | 608,750 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-06-01 Option Award | 2024-06-03 5:06 pm | N/A 2034-05-31 | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 130,000 | $0 | 657,114 (Direct) | View |
2023-04-10 Option Award | 2023-04-11 5:40 pm | N/A 2033-04-09 | DiaMedica Therapeutics Inc. | DMAC | Wambeke David J. Chief Business Officer | 140,000 | $0 | 608,750 (Direct) | View |